TREPHINEX Trademark

Trademark Overview

On Wednesday, November 18, 2020, a trademark application was filed for TREPHINEX with the United States Patent and Trademark Office. The USPTO has given the TREPHINEX trademark a serial number of 90327216. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 24, 2022. This trademark is owned by D&D Biopharmaceuticals Inc.. The TREPHINEX trademark is filed in the Medical Instrument Products category with the following description:

Medical infusion and injection devices for mixing and administering ophthalmic solutions
trephinex

General Information

Serial Number90327216
Word MarkTREPHINEX
Filing DateWednesday, November 18, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 27, 2021

Trademark Statements

Goods and ServicesMedical infusion and injection devices for mixing and administering ophthalmic solutions

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, January 21, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameD&D Biopharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVienna, VA 22182
Party NameD&D Biopharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVienna, VA 22182

Trademark Events

Event DateEvent Description
Monday, October 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2022SOU EXTENSION 1 GRANTED
Monday, March 21, 2022SOU EXTENSION 1 FILED
Monday, March 21, 2022TEAS EXTENSION RECEIVED
Tuesday, September 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, July 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 24, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 7, 2021NON-FINAL ACTION E-MAILED
Friday, May 7, 2021NON-FINAL ACTION WRITTEN
Friday, April 30, 2021ASSIGNED TO EXAMINER
Thursday, January 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 21, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

trephinex administering ophthalmic solutions mixing devices infusion injection medical